Overview

Duration of Protective Effect From Inhaled Ipratropium Bromide on Methacholine Airway Hyperresponsiveness

Status:
Completed
Trial end date:
2008-04-01
Target enrollment:
Participant gender:
Summary
Certain lung disease medications can influence diagnostic tests and research investigations. This study will investigate how long ipratropium bromide must be withheld before a methacholine challenge test can be conducted. This information will be useful for validating current guidelines.
Phase:
Phase 4
Details
Lead Sponsor:
University of Saskatchewan
Collaborator:
Royal University Hospital Foundation
Treatments:
Bromides
Ipratropium
Methacholine Chloride